Paul-Peter Tak
-
Positive Trial Results Position GlaxoSmithKline for Rheumatoid Arthritis Market
GlaxoSmithKline has released positive late-stage clinical trial results for its experimental drug Sirukumab, moving it a step closer to entering…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
